Caxton Associates (New York)’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-16,471
Closed -$679K 392
2023
Q2
$679K Buy
+16,471
New +$540K 0.1% 212
2022
Q1
Sell
-24,681
Closed -$597K 497
2021
Q4
$597K Buy
24,681
+8,974
+57% +$175K 0.06% 229
2021
Q3
$214K Buy
+15,707
New +$113K 0.02% 390

Other funds holding AEHR

Caxton Associates (New York)'s AEHR Position: Q3 2023 in Review

Caxton Associates (New York) sold out of Aehr Test Systems (AEHR) in Q3 2023, closing a stake of 16,471 shares — an estimated $679K sold.

Caxton Associates (New York) first reported a position in AEHR in Q3 2021 and held it in 3 quarters. The position peaked at $679K in Q2 2023. 153 funds tracked by Wall St. Rank hold AEHR as of Q3 2023.

  • Caxton Associates (New York) reported no remaining Aehr Test Systems position as of Q3 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 16,471 Aehr Test Systems shares in Q3 2023, an estimated $679K.
  • Caxton Associates (New York) first reported a position in Aehr Test Systems in Q3 2021 and held it in 3 quarters.
  • Caxton Associates (New York)'s Aehr Test Systems position peaked at $679K in Q2 2023.
  • 153 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2023.

Based on Caxton Associates (New York)'s 13F filing for Q3 2023, filed 14 Nov 2023.